肺癌患者化疗后细菌感染患者C反应蛋白、降钙素原、中性粒细胞及NLR水平研究

doi:10.3969/j.issn.1000-8535.2020.03.013

摘要/Abstract

摘要： 目的探讨C反应蛋白(CRP)、降钙素原(PCT)、中性粒细胞计数(NC)及中性粒细胞/淋巴细胞比值(NLR)在肺癌患者化疗后合并细菌感染早期诊断中的意义。方法收集本院肿瘤科2019年1月—2019年12月肺癌化疗后合并细菌感染患者78例,肺癌化疗后未感染患者64 例,同期健康体检人群39例,采用固相免疫色谱法和速率散射比浊法测定血清中的PCT及CRP 的含量,采用mindray cal8000血细胞分析仪进行血细胞分类计数检查,计算N及NLR。结果化疗后感染组CRP、PCT、NC及NLR均高于化疗未感染组及健康对照组,差异均有统计学意义(P＜0.01);化疗未感染组与健康对照组CRP、PCT、NC及NLR差异有统计学意义(P＜0.01)。CRP、PCT、NC及NLR联合使用时,其灵敏度为97.507%,而特异度升高为97.15%。细菌感染患者治疗前的PCT、CRP、NC及NLR 与治疗后相比较差异有统计学意义(P<0.05),治疗后低于治疗前。结论 PCT、CRP、NC及NLR联合检测能够提高对肺癌患者化疗后合并细菌感染早期诊断的敏感度和特异度。

关键词: 肺癌, 细菌感染, 降钙素原, C-反应蛋白, 中性粒细胞

Abstract: Objective To explore the significance of C-reactive protein (CRP), procalcitonin (PCT), neutrophil count (NC) and neutrophil / lymphocyte ratio (NLR) in the early diagnosis of bacterial infection in lung cancer patients after chemotherapy. Methods From January 2019 to December 2019, 78 cases of lung cancer patients with bacterial infection after chemotherapy, 64 cases of uninfected patients after chemotherapy and 39 cases of healthy people in the same period were collected. the contents of PCT and CRP in serum were detected by solid phase immunosorbent assay and rate nephelometry.The NC and NLR were classified and counted by mindray cal8000 hematology analyzer. Results After chemotherapy, CRP, PCT, NC and NLR in the infected group were higher than those in the uninfected group and the healthy control group (P<0.01), while CRP, PCT, NC and NLR in the uninfected group were higher than those in the healthy control group (P<0.01). When CRP, PCT, NC and NLR were used together, the sensitivity was 97.507%, while the specificity increased by 97.15%. The PCT, CRP, NC and NLR of patients with bacterial infection before treatment were lower than those after treatment (P<0.05). Conclusion PCT, CRP, NC and NLR may improve the sensitivity and specificity of early diagnosis of bacterial infection in patients with lung cancer after chemotherapy.

Key words: Lung cancer, Bacterial infection, Procalcitonin, C-reactive protein, Neutrophil

郑守冰, 王松炎, 欧佳美. 肺癌患者化疗后细菌感染患者C反应蛋白、降钙素原、中性粒细胞及NLR水平研究[J]. 广州医药, 2020, 51(3): 57-60.

ZHENG Shoubing, WANG Songyan, OU Jiamei. Study on the levels of C-reactive protein, procalcitonin, neutrophil count and NLR in patients with bacterial infection after chemotherapy[J]. Guangzhou Medical Journal, 2020, 51(3): 57-60.

参考文献

[1] 曹毛毛,陈万青. 中国恶性肿瘤流行情况及防控现状[J]. 中国肿瘤临床,2019,46(13):145-149.
[2] 张为民,谢波.非小细胞肺癌免疫治疗进展[J]. 实用医学杂志,2019,35(4):507-511.
[3] KANG D H, KIM J O, JUNG S S, et al. Efficacy of vinorelbine monotherapy as third-or further-line therapy in patients with advanced non-small-cell lung cancer[J]. Oncol, 2019, 3(23):1-9.
[4] BAO Q, ZHOU H, CHEN X, et al. Characteristics and influencing factors of pathogenic bacteria in lung cancer chemotherapy combined with nosocomial pulmonary infection[J]. Zhongguo Fei Ai Za Zhi,2019,22(12):772-778.
[5] 李有军,余华,张克斌.细菌感染在促进肺癌发生与发展及治疗中的作用研究进展[J]. 中华医院感染学杂志,2018,28(17):2716-2720.
[6] WU J, JIN Y U, LI H, et al. Evaluation and significance of C-reactive protein in the clinical diagnosis of severe pneumonia[J]. Exp Ther Med,2015,10(1):175-180.
[7] JUN K R, LEE J N, SONG S A, et al. Serial changes in serum procalcitonin, interleukin 6, and C-reactive protein levels according to non-specific surgical stimulation[J]. Clin Chem Lab Med,2015,53(4):549-558.
[8] 江源,陈建国,刘明广, 等. 降钙素原C反应蛋白中性粒细胞与淋巴细胞计数比值对肺癌患者肺部感染的临床意义[J]. 实用医技杂志,2018,25(6):587-589.
[9] 杨龙海,叶波,魏星,等. 最新国际肺癌TNM分期标准(第8版)修订稿解读[J]. 中国医刊,2016,51(9):22-25.
[10] XIAO X, WANG S, LONG G. C-reactive protein is a significant predictor of improved survival in patients with advanced non-small cell lung cancer[J]. Med (Baltimore),2019,98(26):e16238.
[11] 戴方娣.血清淀粉样蛋白A联合C-反应蛋白检测在新生儿发热诊断中的价值[J]. 中国妇幼保健,2019,34(19):4491-4494.
[12] MILCENT K, GAJDOS V. Use of Procalcitonin assays to predict serious bacterial infection in young febrile infants-reply[J]. JAMA Pediatr, 2016,170(6):623-624.
[13] 孙红梅,陈文彰.降钙素原、白细胞、中性粒细胞比例、超敏C反应蛋白对恶性肿瘤患者发热的诊断价值[J]. 现代肿瘤医学,2019,27(1):127-130.
[14] WANG Z S.Prognosis value of inflammatory prognostic index based on c reactive protein,neutrophil lymphocyte ratio and seruln albumin in pafients with non-small cell lung cancer[J]. J Clinical Pulm Med,2018(1): 160-164.
[15] 陈崇,周桃玉,温旺荣.中性粒细胞/淋巴细胞计数与降钙素原对肿瘤患者合并细菌感染的诊断价值[J]. 现代肿瘤医学,2019,27(10):1786-1788.
[16] 刘乐乐,李华.中性粒细胞和淋巴细胞VCS参数与NLR对肿瘤患者化疗后细菌感染辅助诊断价值[J]. 中华肿瘤防治杂志,2019,26(3):190-193.
[17] LI X, ZENG W H, ZHOU Y Q, et al. Neutrophil-to-lymphocyte ratio predicted long-term chemotherapy benefits in stage iiib-iv non-squamous non-small cell lung cancer patients without sensitive mutations[J]. Onco Targets Ther,2019(10):8779-8787.
[18] KIRIU T, YAMAMOTO M, NAGANO T, et al. Pseudo-progression and the neutrophil-to-lymphocyte ratio in non-small cell lung cancer treated with immune checkpoint inhibitors: a case-control study[J]. Onco Targets Ther, 2019(12):10559-10568.
[19] TAKADA K, KASHIWAGI S, ASANO Y, et al. Clinical evaluation of dynamic monitoring of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in primary endocrine therapy for advanced breast cancer[J]. Anticancer Res,2019,39(10):5581-5588.